Overview
uniQure is a leading gene therapy company advancing transformative therapies for patients with severe medical needs. It is working to deliver on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and cardiovascular diseases.